Side-effect test of sorafenib using 3-D skin equivalent based on microfluidic skin-on-a-chip

[Display omitted] Sorafenib is a neovascular blocker that prevents the formation of new blood vessels, and by consequence, the growth of cancer tissue, through multiple kinase inhibitors that target angiogenesis. However, several side effects have been reported by patients on sorafenib. Therefore, t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of industrial and engineering chemistry (Seoul, Korea) 2020, 82(0), , pp.71-80
Main Authors: Jeon, Hye Mi, Kim, Kyunghee, Choi, Kyung Chan, Sung, Gun Yong
Format: Article
Language:English
Subjects:
Human-skin equivalents
Microphysiological system
Preclinical evaluation
Skin-on-a-chip
Sorafenib
화학공학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] Sorafenib is a neovascular blocker that prevents the formation of new blood vessels, and by consequence, the growth of cancer tissue, through multiple kinase inhibitors that target angiogenesis. However, several side effects have been reported by patients on sorafenib. Therefore, this study investigates the skin side effects of sorafenib as revealed by hematoxylin and eosin (H&E) staining, real-time polymerase chain reaction (RT-PCR), and immunohistochemical staining results using a human skin equivalent model produced from human fibroblast and keratinocyte. Thickening of the granules and the protein expressed through the changes on the granular layer, similar to the tissues of an actual patient, was observed. It is expected that the findings of this study will greatly improve the preclinical evaluations and promote the use of the skin-on-a-chip system for evaluating the side effects of drugs and the efficacy of cosmetics.
ISSN:1226-086X
1876-794X
DOI:10.1016/j.jiec.2019.09.044